Abortion pill case to be heard by conservative, anti-abortion panel
Send a link to a friend
[May 09, 2023]
By Brendan Pierson and Jacqueline Thomsen
(Reuters) - A case brought by anti-abortion groups seeking to ban the
abortion pill mifepristone nationwide will be heard next week by a panel
of three deeply conservative judges hostile to abortion rights, a
federal appeals court revealed on Monday.
The Biden administration is expected to urge the 5th U.S. Circuit Court
of Appeals panel in New Orleans on May 17 to overturn a court order that
suspended the federal government's approval of mifepristone.
The administration will be appealing to Circuit Judges Jennifer Walker
Elrod, who upheld a Texas law making it more difficult for abortion
clinics to operate in the state; James Ho, who has called abortion a
"moral tragedy"; and Cory Wilson, who supported abortion bans as a
Mississippi state legislator.
The U.S. Food and Drug Administration, which is named as the defendant
in the lawsuit, did not immediately respond to requests for comment.
Ho did not immediately return a request for comment. A Wilson staffer
said he does not comment on pending cases, and a staffer for Elrod
referred Reuters to the court's clerk's office, which said it could not
comment.
Mifepristone is part of the two-drug regimen used in medication
abortion, which accounts for more than half of U.S. abortions.
Led by the recently formed Alliance for Hippocratic Medicine, abortion
foes claimed in a lawsuit last year that mifepristone is dangerous and
that the FDA approved it unlawfully in 2000. Scientific studies have
overwhelmingly concluded that the drug, which has been used by millions
of women, is safe.
U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas last month
sided with the plaintiffs, finding they were likely to win, and
suspended mifepristone's approval while their lawsuit goes forward. The
U.S. Supreme Court put that order on hold, meaning that mifepristone
remains available while the case is appealed.
In filings last week, the FDA and mifepristone maker Danco Laboratories
said Kacsmaryk's order would both harm the public and destabilize the
pharmaceutical industry.
The plaintiffs are expected to file a response brief later on Monday.
[to top of second column]
|
Used boxes of Mifepristone, the first
pill in a medical abortion, line a trash can at Alamo Women's Clinic
in Carbondale, Illinois, U.S., April 20, 2023. REUTERS/Evelyn
Hockstein
"Despite those who insist on playing
politics and endangering the lives of girls and women, we look
forward to a final outcome in this case that will hold the FDA
accountable," Erik Baptist, a lawyer for the plaintiffs, said in a
statement.
Ho, who was appointed by former Republican
president Donald Trump, was part of a 5th Circuit panel that in 2019
blocked Mississippi's 15-week ban on abortions, but in a separate
opinion spoke out against the constitutional right to abortion.
The Supreme Court's conservative majority last year used the same
case to overturn its landmark 1973 Roe v. Wade decision and find
there was no right to abortion enshrined in the U.S. Constitution.
In 2021, Ho was in the majority in a 2-1 ruling refusing to block
Texas's six-week abortion ban. The Supreme Court later let that law
go into effect.
Ho last month also spoke to the conservative Federalist Society's
Dallas chapter in defense of Kacsmaryk, who he called a friend,
after the Washington Post reported the then-nominee did not disclose
to the U.S. Senate ahead of his confirmation hearing a law review
article he helped write that criticized protections for people
seeking abortions.
Elrod, who was appointed by former Republican president George W.
Bush, in 2019 wrote the majority opinion for a 5th Circuit decision
striking down a key part of the Obamacare health insurance law.
Wilson, another Trump appointee, as a state legislator voted to ban
abortion once fetal cardiac activity is detected, around six weeks.
Whichever party loses the appeal would be able to ask for en banc
rehearing from the full 5th Circuit, which has 12 Republican
appointees among 16 active judges serving on the court, and then
appeal to the Supreme Court.
(Reporting By Brendan Pierson in New York and Jacqueline Thomsen in
Washington, D.C., Editing by Alexia Garamfalvi and Bill Berkrot)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |